FIELD: medicine.
SUBSTANCE: there are described chimeric peptides able to inhibit or attenuate a viral infection. The peptides contain a primary structure which contains at least one segment which delays activation of NS3 protease of virus family Flaviviridae, and a segment penetrating into a cell. What is also disclosed is a pharmaceutical composition containing such chimeric peptides.
EFFECT: invention may be used in medicine.
5 cl, 6 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| mRNA-BASED IMMUNOBIOLOGICAL AGENT FOR PREVENTION OF DISEASES CAUSED BY TICK-BORNE ENCEPHALITIS VIRUS | 2024 |
|
RU2823754C1 |
| INFECTIOUS CLONES OF FULL-SIZED CDNA OF TICK FLAVIVIRUS | 2001 |
|
RU2288266C2 |
| METHOD FOR IMMUNE THERAPY OF CHRONIC VIRAL HEPATITIS C | 2016 |
|
RU2637631C2 |
| RESISTANT MUTANTS OF PROTEASE NS3-NS4A HCV | 2004 |
|
RU2365624C2 |
| COMPOSITION FOR TREATING HEPATITIS C AND METHOD OF TREATING HEPATITIS C | 2010 |
|
RU2447899C2 |
| METHOD OF PRODUCING ANTIGEN OF ZIKA VIRUS, HAVING IMMUNOGENIC AND ANTIGENIC PROPERTIES | 2019 |
|
RU2717993C1 |
| SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS AND FLUORESCENT-LABELLED PROBE FOR JMTV RNA IDENTIFICATION BY PCR WITH HYBRIDISATION-FLUORESCENCE DETECTION | 2023 |
|
RU2818960C1 |
| PVEAL3-10H10CH PLASMID GENETIC CONSTRUCT, STRAIN OF CHO-K1-10H10CH RECOMBINANT CELL LINE AND 10H10CH CHIMERIC ANTIBODY AGAINST TICK-BORNE ENCEPHALITIS VIRUS PRODUCED BY THE INDICATED STRAIN OF CHO-K1-10H10CH CELL LINE | 2022 |
|
RU2800471C1 |
| PEPTIDE DERIVATIVES OF 1-(1-ADAMANTYL)ETHYLAMINE AND THEIR ANTIVIRAL ACTION | 2013 |
|
RU2524216C1 |
| RECOMBINANT PLASMID DNA PC-NS3 PROVIDING INTEGRATION OF COMPLEX OF GENES C, PRM, E, NS1, NS 2A, NS 2B, NS3 OF TICK-BORNE ENCEPHALITIS VIRUS IN GENOME OF BOVINE VACCINE VIRUS AND RECOMBINANT STRAIN OF BOVINE VACCINE VIRUS EXPRESSING COMPLEX OF GENES C, PRM, E, NS1, NS 2A, NS2B, NS3 OF TICK-BORNE ENCEPHALITIS VIRUS IN IMMUNIZED ORGANISM CELLS | 1995 |
|
RU2112038C1 |
